Response-range calibration of a bioassay equivalence margin chooses a curve-shape tolerance from the permitted change in relative biological potency over a specified response interval. It makes explicit why the same slope-ratio limit need not suit different response ranges. Here calibration means setting an assay-design tolerance, rather than measurement calibration of an instrument.
For an original local dose-response relationship, write and , where is the natural logarithm of concentration and both slopes are positive. Equal-effect log-concentration separation is . Across a response interval of width , its change is . Requiring the equal-effect concentration ratio to change by no more than a stipulated multiplicative tolerance gives
Set and . For , the resulting bioassay parallelism equivalence margin is
If , this particular constraint supplies no finite upper bound on ; the lower bound remains . The intercepts affect the potency level but cancel from its drift across the interval.
An original design example takes response units, response units per natural-log concentration, and . Then , giving approximately . Halving the response interval doubles and relaxes these slope bounds. Rescaling the response measurement multiplies and together and leaves unchanged: the result depends on the experimental interval, not the arbitrary response units.
An equivalence test must still account for uncertainty in the estimated slope ratio. These local linear bounds do not establish matching plateaus in a nonlinear dose-response relationship. In the primary rituximab-standard collaborative study, analysts assessed multiple curve parameters and obtained study-specific limits from coded duplicates; those limits were explicitly not routine laboratory validity criteria.[ref] Select the response interval and tolerated potency drift before inspecting the test preparation's disagreement.

Articles by others on the same topic (0)

There are currently no matching articles.